You are here

Record year for pharma deals but firms fail to sell mature-drug portfolios


IN A record year for healthcare acquisitions, some of the largest pharmaceutical companies tried to sell their portfolios of older drugs - and failed.

Drug companies have agreed to about US$260 billion of deals so far in 2014, the most since at least 2002 and more than twice